Four pillars of precision drug delivery: understanding the science behind MagicTouch.
Explore how the drug, carrier, coating technology, and transfer & retention work together to support targeted sirolimus delivery to the vessel wall during brief balloon inflation.
A brief inflation. Targeted drug delivery. A therapeutic effect designed to continue beyond the procedure.
MagicTouch™ Monday continues its journey into the science of precision drug delivery. In this episode, we look beyond the concept of a drug-coated balloon and explore what happens during the brief period of balloon inflation and why the drug, carrier, coating and transfer process all matter.
A drug-coated balloon (DCB) has a limited window to deliver an anti-proliferative drug to the vessel wall. The objective is not simply to deliver the drug, but to deliver it to the intended treatment area, support its transfer and enable it to remain there after the balloon is removed.
So, what makes a drug-coated balloon actually work? Judge it on four things.
The Challenge: One Job. Seconds to Do It.
During a brief inflation period, the balloon is designed to deliver an anti-proliferative drug to the vessel wall, with the intended drug effect continuing after balloon removal. Unlike a stent, a drug-coated balloon does not leave behind a permanent implant.
That short delivery window makes the design particularly important. Four pillars help explain the process.
Pillar 1 — The Drug: Start With the Right Molecule
The first part of the equation is the drug. MagicTouch™ uses sirolimus, a limus molecule with cytostatic and anti-proliferative properties and a wide therapeutic window. The technology is designed to deliver the molecule to the vessel wall, where it can influence the vessel’s healing response.
Choosing the molecule is an important starting point. But the drug also needs to travel from the balloon surface to the target tissue. That brings us to the carrier.
Pillar 2 — The Carrier: Travel and Stay
Sirolimus needs help to cross into the tissue and remain there.
For a drug-coated balloon, delivering the drug to the vessel wall is only part of the challenge. The drug also needs to be transferred into the tissue and retained where it is intended to act.
Nanolute™ Technology encapsulates sirolimus in sub-micron phospholipid particles. The technology is designed to support drug protection, transfer to the vessel wall and retention at the target site.
The carrier forms an important link between the drug on the balloon and the tissue where it is delivered.
Pillar 3 — The Coating Technology: Even Coverage. Minimal Waste.
The coating is another important part of drug delivery. MagicTouch™ uses a circumferential, uniform coating designed to provide homogeneous drug distribution to the target lesion while minimizing drug loss during transit.
A uniform coating is intended to support consistent drug delivery across the treated area. The coating is therefore not simply a layer on the balloon; it is part of the overall drug-delivery design.
Pillar 4 — Transfer & Retention: Right Place. Not the Wrong Places.
The final part of the process is what happens during inflation. The drug is designed to transfer to the prepared vessel wall and remain in the tissue after the balloon is retrieved. The intended drug action is designed to continue beyond the brief period of balloon inflation.
The goal is not simply to place a drug on a balloon. It is to design the delivery process around getting the drug to the intended treatment site.
Designed to stay where it’s delivered.
Bringing the Four Pillars Together
A drug-coated balloon is not defined by its drug alone. Its performance depends on how the four pillars work together: drug, carrier, coating technology, and transfer & retention.
For MagicTouch™, these pillars come together through sirolimus and Nanolute™ Technology, with a circumferential coating designed to support homogeneous drug distribution and transfer to the vessel wall.
Drug → Carrier → Coating Technology → Transfer & Retention
Continue the Journey
Understanding these four pillars helps explain how a drug-coated balloon is designed to deliver its drug during a brief inflation and support retention after balloon retrieval.
Read EP. 01 — The Science of Precision Drug Delivery
Explore the MagicTouch SCB product page
The story continues. Stay tuned for another deep dive.
Question the claim. Read the method. Follow the Molecule.
References
[1] Concept Medical. MagicTouch SCB — Sirolimus-Coated Balloon Catheter, product and Nanolute technology information.
[2] Concept Medical. MagicTouch SCB — Clinical Evidence.
Disclaimer
For Healthcare Professionals Only. This content is for illustrative and informational purposes only and is not intended as medical advice. Approved indications and product availability may vary by region. MagicTouch™ is not approved for commercial use in the United States. Please refer to applicable local product labelling and Instructions for Use for complete information.
